1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal OTC Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Laxatives
1.4.3 Anti-Flatulents
1.4.4 H2-Antaginists
1.4.5 Anti-Diarrheals
1.4.6 PPIs
1.4.7 Anti-Emetics
1.4.8 Other
1.5 Market by Application
1.5.1 Global Gastrointestinal OTC Drugs Market Share by Application: 2021-2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Gastrointestinal OTC Drugs Market
1.8.1 Global Gastrointestinal OTC Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Gastrointestinal OTC Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Gastrointestinal OTC Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Gastrointestinal OTC Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global Gastrointestinal OTC Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America Gastrointestinal OTC Drugs Sales Volume
3.3.1 North America Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Gastrointestinal OTC Drugs Sales Volume
3.4.1 East Asia Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Gastrointestinal OTC Drugs Sales Volume (2015-2020)
3.5.1 Europe Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Gastrointestinal OTC Drugs Sales Volume (2015-2020)
3.6.1 South Asia Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Gastrointestinal OTC Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Gastrointestinal OTC Drugs Sales Volume (2015-2020)
3.8.1 Middle East Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Gastrointestinal OTC Drugs Sales Volume (2015-2020)
3.9.1 Africa Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Gastrointestinal OTC Drugs Sales Volume (2015-2020)
3.10.1 Oceania Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Gastrointestinal OTC Drugs Sales Volume (2015-2020)
3.11.1 South America Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Gastrointestinal OTC Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World Gastrointestinal OTC Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Gastrointestinal OTC Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Gastrointestinal OTC Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Gastrointestinal OTC Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Gastrointestinal OTC Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Gastrointestinal OTC Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Gastrointestinal OTC Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Gastrointestinal OTC Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Gastrointestinal OTC Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Gastrointestinal OTC Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Gastrointestinal OTC Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Gastrointestinal OTC Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Gastrointestinal OTC Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global Gastrointestinal OTC Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global Gastrointestinal OTC Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Gastrointestinal OTC Drugs Consumption Volume by Application (2015-2020)
15.2 Global Gastrointestinal OTC Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Gastrointestinal OTC Drugs Business
16.1 GlaxoSmithKline
16.1.1 GlaxoSmithKline Company Profile
16.1.2 GlaxoSmithKline Gastrointestinal OTC Drugs Product Specification
16.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Sanofi
16.2.1 Sanofi Company Profile
16.2.2 Sanofi Gastrointestinal OTC Drugs Product Specification
16.2.3 Sanofi Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Bayer
16.3.1 Bayer Company Profile
16.3.2 Bayer Gastrointestinal OTC Drugs Product Specification
16.3.3 Bayer Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Pfizer
16.4.1 Pfizer Company Profile
16.4.2 Pfizer Gastrointestinal OTC Drugs Product Specification
16.4.3 Pfizer Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Abbott
16.5.1 Abbott Company Profile
16.5.2 Abbott Gastrointestinal OTC Drugs Product Specification
16.5.3 Abbott Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Johnson & Johnson
16.6.1 Johnson & Johnson Company Profile
16.6.2 Johnson & Johnson Gastrointestinal OTC Drugs Product Specification
16.6.3 Johnson & Johnson Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Nestle
16.7.1 Nestle Company Profile
16.7.2 Nestle Gastrointestinal OTC Drugs Product Specification
16.7.3 Nestle Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Perrigo
16.8.1 Perrigo Company Profile
16.8.2 Perrigo Gastrointestinal OTC Drugs Product Specification
16.8.3 Perrigo Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Procter & Gamble
16.9.1 Procter & Gamble Company Profile
16.9.2 Procter & Gamble Gastrointestinal OTC Drugs Product Specification
16.9.3 Procter & Gamble Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Teva Pharmaceutical
16.10.1 Teva Pharmaceutical Company Profile
16.10.2 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Specification
16.10.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Boehringer Ingelheim
16.11.1 Boehringer Ingelheim Company Profile
16.11.2 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Specification
16.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Reckitt Benckiser
16.12.1 Reckitt Benckiser Company Profile
16.12.2 Reckitt Benckiser Gastrointestinal OTC Drugs Product Specification
16.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Purdue Pharma
16.13.1 Purdue Pharma Company Profile
16.13.2 Purdue Pharma Gastrointestinal OTC Drugs Product Specification
16.13.3 Purdue Pharma Gastrointestinal OTC Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Gastrointestinal OTC Drugs Manufacturing Cost Analysis
17.1 Gastrointestinal OTC Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Gastrointestinal OTC Drugs
17.4 Gastrointestinal OTC Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Gastrointestinal OTC Drugs Distributors List
18.3 Gastrointestinal OTC Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Gastrointestinal OTC Drugs (2021-2026)
20.2 Global Forecasted Revenue of Gastrointestinal OTC Drugs (2021-2026)
20.3 Global Forecasted Price of Gastrointestinal OTC Drugs (2015-2026)
20.4 Global Forecasted Production of Gastrointestinal OTC Drugs by Region (2021-2026)
20.4.1 North America Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Gastrointestinal OTC Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Gastrointestinal OTC Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Gastrointestinal OTC Drugs by Country
21.2 East Asia Market Forecasted Consumption of Gastrointestinal OTC Drugs by Country
21.3 Europe Market Forecasted Consumption of Gastrointestinal OTC Drugs by Countriy
21.4 South Asia Forecasted Consumption of Gastrointestinal OTC Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Gastrointestinal OTC Drugs by Country
21.6 Middle East Forecasted Consumption of Gastrointestinal OTC Drugs by Country
21.7 Africa Forecasted Consumption of Gastrointestinal OTC Drugs by Country
21.8 Oceania Forecasted Consumption of Gastrointestinal OTC Drugs by Country
21.9 South America Forecasted Consumption of Gastrointestinal OTC Drugs by Country
21.10 Rest of the world Forecasted Consumption of Gastrointestinal OTC Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer